Sunita Sunita

Sunita Sunita

Auto-generated profile, based on publicly available information

Sunita Sunita

Doctoral Study Program Faculty of Medicine, Universitas Padjadjaran, Bandung, West Java, Indonesia

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2026 in Obesity Science & Practice
Verified
Journal Article
Open access
SSSunita Sunita
Sunita Sunita
MGMohammad Ghozali
Mohammad Ghozali
MAMohammad Rizki Akbar
Mohammad Rizki Akbar
ANAnnisa Dewi Nugrahani
Annisa Dewi Nugrahani
IRIis Inayati Rakhmat
Iis Inayati Rakhmat
TATri Hanggono Achmad
Tri Hanggono Achmad
Background: Adipokines are dysregulated in obesity and exacerbate proinflammatory conditions. Although several studies have investigated adipokine levels in obesity, their findings have been inconsistent, leaving the precise nature of these alterations uncertain. This systematic review and meta‐analysis aimed to provide an updated overview of circulating adipokines, particularly adiponectin, leptin, fibroblast growth factor 21 (FGF21), growth differentiation factor 15 (GDF15), interleukin‐6 (IL‐6), and tumor necrosis factor‐α (TNF‐α) in the context of obesity. Methods: This study adhered to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines and PROSPERO registration (CRD42024525103). PubMed/MEDLINE, Scopus, and Journal of Clinical Investigation databases were searched from inception to August 25, 2025. Eligible observational studies were assessed using the ROBINS‐I and GRADE frameworks. Standardized mean differences (SMDs) were calculated using a random‐effects model. Results: From 2378 records, 30 and 16 studies were included in the review and meta‐analysis, respectively. Adiponectin levels were significantly lower in persons with obesity than in those with normal weight ( p = 0.007). Conversely, leptin, TNF‐α, and FGF21 levels were significantly higher in persons with obesity ( p < 0.01). No significant differences were found for GDF15 ( p = 0.62) and IL‐6 ( p = 0.17). Conclusions: Adiponectin, leptin, TNF‐α, and FGF21 show consistent directionality and may serve as robust biomarkers in obesity‐related risk profiling. Conversely, GDF15 and IL‐6 exhibit context‐dependent variability. Further prospective cohort studies are warranted to better understand these adipokines, as persons with normal weight may still be at a high risk of cardiometabolic diseases.

20 June 2026 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
SSSunita Sunita
Sunita Sunita
MSMas Rizky A. A Syamsunarno
Mas Rizky A. A Syamsunarno
MAMohammad Rizki Akbar
Mohammad Rizki Akbar
ANAnnisa Dewi Nugrahani
Annisa Dewi Nugrahani
NSNova Sylviana
Nova Sylviana
TATri Hanggono Achmad
Tri Hanggono Achmad
Background: Adipose tissue secretes adipokines, bioactive proteins that regulate inflammation and cardiometabolic processes. During acute myocardial infarction (AMI), adipokine profiles may vary according to body mass index (BMI), yet this association remains underexplored. Aims: To compare circulating adiponectin, fibroblast growth factor 21 (FGF21), growth differentiation factor 15 (GDF15), and interleukin-6 (IL-6) between non-obese and obese patients with AMI. Methods: In this cross-sectional study, 105 patients with AMI were stratified as non-obese (BMI < 25 kg/m², n = 62) or obese (BMI ≥ 25 kg/m², n = 43). Serum adiponectin, GDF15, and IL-6 were measured by Luminex, and FGF21 was measured by ELISA. Clinical variables and lipid indices were compared between BMI groups, and correlation analyses were performed. Results: Although myocardial injury levels were comparable between the two groups, non-obese patients had significantly higher serum levels of adiponectin, FGF21, GDF15, and IL-6 than obese patients (all p < 0.05). In all patients, adiponectin was negatively correlated with total cholesterol, LDL-c, and triglycerides, and positively correlated with HDL-c; however, these associations were not consistently observed within BMI subgroups after stratification and FDR correction. GDF15 and IL-6 also showed inverse correlations with selected lipid parameters in all patients. Conclusion: Non-obese AMI patients exhibited higher levels of adiponectin, FGF21, GDF15, and IL-6 compared to obese AMI patients. These adipokine profiles were associated with lipid parameters, notably showing inverse correlations between adiponectin and GDF15 with total cholesterol and LDL-c. These findings highlight the association between adiposity and early metabolic responses in AMI across BMI categories.